Bead-based multiplex genotyping of human papillomaviruses

Journal of Clinical Microbiology

Volumn 44, Issue 2, 2006, Pages 504-512

  Schmitt, Markus ^a   Bravo, I G ^a   Snijders, Peter J F ^b   Gissmann, Lutz ^a   Pawlita, Michael ^a   Waterboer, Tim ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORESCENT DYE; POLYSTYRENE; VIRUS DNA;

ARTICLE; DIAGNOSTIC VALUE; DNA HYBRIDIZATION; EPIDEMIOLOGICAL DATA; GENOTYPE; HIGH THROUGHPUT SCREENING; HUMAN; LUMINEX SUSPENSION ARRAY TECHNOLOGY; NANOTECHNOLOGY; NONHUMAN; NUCLEOTIDE SEQUENCE; OLIGONUCLEOTIDE PROBE; PAPILLOMA VIRUS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; REVERSE LINE BLOT ASSAY; UNINDEXED SEQUENCE; VACCINATION; VALIDATION PROCESS; VIRUS TYPING;

CERVIX UTERI; FEMALE; GENOTYPE; HUMANS; MICROSPHERES; OLIGONUCLEOTIDE PROBES; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; POLYSTYRENES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

DNA VIRUSES; HUMAN PAPILLOMAVIRUS; PAPILLOMAVIRIDAE;

EID: 32344434062     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.44.2.504-512.2006     Document Type: Article

References (25)

1. Armstrong, B., M. Stewart, and A. Mazumder. 2000. Suspension arrays for high throughput, multiplexed single nucleotide polymorphism genotyping. Cytometry 40:102-108.
2. Bosch, F. X., and S. de Sanjose. 2003. Chapter 1: human papillomavirus and cervical cancer-burden and assessment of causality. J. Natl. Cancer Inst. Monogr. 31:3-13.
3. Bosch, F. X., A. Lorincz, N. Munoz, C. J. Meijer, and K. V. Shah. 2002. The causal relation between human papillomavirus and cervical cancer. J. Clin. Pathol. 55:244-265.
4. Bulkmans, N. W., M. C. Bleeker, J. Berkhof, F. J. Voorhorst, P. J. Snijders, and C. J. Meijer. 2005. Prevalence of types 16 and 33 is increased in high-risk human papillomavirus positive women with cervical intraepithelial neoplasia grade 2 or worse. Int. J. Cancer 117:177-181.
5. Bulkmans, N. W., L. Rozendaal, P. J. Snijders, F. J. Voorhorst, A. J. Boeke, G. R. Zandwijken, F. J. van Kemenade, R. H. Verheijen, K. v Groningen, M. E. Boon, H. J. Keuning, M. van Ballegooijen, A. J. van den Brule, and C. J. Meijer. 2004. POBASCAM, a population-based randomized controlled trial for implementation of high-risk HPV testing in cervical screening: design, methods and baseline data of 44,102 women. Int. J. Cancer 110:94-101.
6. Dannecker, C., U. Siebert, C. J. Thaler, D. Kiermeir, H. Hepp, and P. Hillemanns. 2004. Primary cervical cancer screening by self-sampling of human papillomavirus DNA in internal medicine outpatient clinics. Ann. Oncol. 15:863-869.
7. de Roda Husman, A. M., J. M. Walhoomers, A. J. van den Brule, C. J. Meijer, and P. J. Snijders. 1995. The use of general primers GP5 and GP6 elongated at their 3′ ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J. Gen. Virol. 76(Part 4):1057-1062.
8. Dunbar, S., R. Godbout, H. Newkirk, and J. Hetzel. 2003. Microsphere suspension array technology for SNP detection in cattle. IEEE Eng. Med. Biol. Mag. 22:158-162.
9. Dunbar, S. A., C. A. Vander Zee, K. G. Oliver, K. L. Karem, and J. W. Jacobson. 2003. Quantitative, multiplexed detection of bacterial pathogens: DNA and protein applications of the Luminex LabMAP system. J. Microbiol. Methods 53:245-252.
10. Gravitt, P. E., C. L. Peyton, T. Q. Alessi, C. M. Wheeler, F. Coutlee, A. Hildesheim, M. H. Schiffman, D. R. Scott, and R. J. Apple. 2000. Improved amplification of genital human papillomaviruses. J. Clin. Microbiol. 38:357-361.
11. Gravitt, P. E., C. L. Peyton, R. J. Apple, and C. M. Wheeler. 1998. Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a single-hybridization, reverse line blot detection method. J. Clin. Microbiol. 36:3020-3027.
12. Jacobs, M. V., P. J. Snijders, A. J. van den Brule, T. J. Helmerhorst, C. J. Meyer, and J. M. Walboomers. 1997. A general primer GP5+/GP6(+)-mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings. J. Clin. Microbiol. 35:791-795.
13. Jin, X. W., K. Zanotti, and B. Yen-Lieberman. 2005. New cervical cancer screening strategy: combined Pap and HPV testing. Cleveland Clin. J. Med. 72:141-148.
14. Kleter, B., L. J. van Doorn, L. Schrauwen, A. Molijn, S. Sastrowijoto, J. ter Schegget, J. Lindeman, B. ter Harmsel, M. Burger, and W. Quint. 1999. Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus. J. Clin. Microbiol. 37:2508-2517.
15. Munoz, N., F. X. Bosch, S. de Sanjose, R. Herrero, X. Castellsague, K. V. Shah, P. J. Snijders, and C. J. Meijer. 2003. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N. Engl. J. Med. 348:518-527.
16. Munoz, N., S. Franceschi, C. Bosetti, V. Moreno, R. Herrero, J. S. Smith, K. V. Shah, C. J. Meyer, and F. X. Bosch. 2002. Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case-control study. Lancet 359:1093-1101.
17. Nieminen, P., S. Vuorma, M. Viikki, M. Hakama, and A. Anttila. 2004. Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer. BJOG 111:842-848.
18. Notredame, C., D. G. Higgins, and J. Heringa. 2000. T-Coffee: a novel method for fast and accurate multiple sequence alignment. J. Mol. Biol. 302:205-217.
19. Parkin, D. M., F. I. Bray, and S. S. Devesa. 2001. Cancer burden in the year 2000. The global picture. Eur. J. Cancer 37(Suppl. 8):S4-S66.
20. van den Brule, A. J., R. Pol, N. Fransen-Daalmeijer, L. M. Schouls, C. J. Meyer, and P. J. Snijders. 2002. GP5+/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes. J. Clin. Microbiol. 40:779-787.
21. Walboomers, J. M., M. V. Jacobs, M. M. Manos, F. X. Bosch, J. A. Kummer, K. V. Shah, P. J. Snijders, J. Peto, C. J. Meijer, and N. Munoz. 1999. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol. 189:12-19.
22. Wallace, J., B. A. Woda, and G. Pihan. 2005. Facile, comprehensive, high-throughput genotyping of human genital papillomaviruses using spectrally addressable liquid bead microarrays. J. Mol. Diagn. 7:72-80.
23. Waterboer, T., P. Sehr, K. M. Michael, S. Franceschi, J. D. Nieland, T. O. Joos, M. F. Templin, and M. Pawlita. 2005. Multiplex human papillomavirus serology based on in situ-purified glutathione S-transferase fusion proteins. Clin. Chem. 51:1845-1853.
24. Ye, F., M. S. Li, J. D. Taylor, Q. Nguyen, H. M. Colton, W. M. Casey, M. Wagner, M. P. Weiner, and J. Chen. 2001. Fluorescent microsphere-based readout technology for multiplexed human single nucleotide polymorphism analysis and bacterial identification. Hum. Mutat. 17:305-316.
25. zur Hausen, H. 2002. Papillomaviruses and cancer: from basic studies to clinical application. Nat. Rev. Cancer 2:342-350.